[go: up one dir, main page]

AU2001266940A1 - Vaccine for congenital tremors in pigs - Google Patents

Vaccine for congenital tremors in pigs

Info

Publication number
AU2001266940A1
AU2001266940A1 AU2001266940A AU6694001A AU2001266940A1 AU 2001266940 A1 AU2001266940 A1 AU 2001266940A1 AU 2001266940 A AU2001266940 A AU 2001266940A AU 6694001 A AU6694001 A AU 6694001A AU 2001266940 A1 AU2001266940 A1 AU 2001266940A1
Authority
AU
Australia
Prior art keywords
pigs
vaccine
congenital tremors
tremors
congenital
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001266940A
Inventor
Jiwon Choi
Charles L. Kanitz
Matti Kiupel
Suresh K Mittal
Gregory W. Stevenson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Purdue Research Foundation
Original Assignee
Purdue Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Purdue Research Foundation filed Critical Purdue Research Foundation
Publication of AU2001266940A1 publication Critical patent/AU2001266940A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001266940A 2000-06-15 2001-06-15 Vaccine for congenital tremors in pigs Abandoned AU2001266940A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21171000P 2000-06-15 2000-06-15
US60211710 2000-06-15
PCT/US2001/019220 WO2001096377A2 (en) 2000-06-15 2001-06-15 Vaccine for congenital tremors in pigs

Publications (1)

Publication Number Publication Date
AU2001266940A1 true AU2001266940A1 (en) 2001-12-24

Family

ID=22788038

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001266940A Abandoned AU2001266940A1 (en) 2000-06-15 2001-06-15 Vaccine for congenital tremors in pigs

Country Status (6)

Country Link
EP (1) EP1290016A2 (en)
JP (1) JP2004503234A (en)
AU (1) AU2001266940A1 (en)
CA (1) CA2410229A1 (en)
MX (1) MXPA02012352A (en)
WO (1) WO2001096377A2 (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2772047B1 (en) 1997-12-05 2004-04-09 Ct Nat D Etudes Veterinaires E GENOMIC SEQUENCE AND POLYPEPTIDES OF CIRCOVIRUS ASSOCIATED WITH PIGLET LOSS DISEASE (MAP), APPLICATIONS TO DIAGNOSIS AND TO PREVENTION AND / OR TREATMENT OF INFECTION
US20040062775A1 (en) 1997-12-05 2004-04-01 Agence Francaise De Securite Sanitaire Des Aliments Circovirus sequences associated with piglet weight loss disease (PWD)
US7276353B2 (en) 2001-12-12 2007-10-02 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
US7279166B2 (en) 2001-12-12 2007-10-09 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
GB0318096D0 (en) * 2003-08-01 2003-09-03 Queen Mary & Westfield College Vaccine
US7833707B2 (en) 2004-12-30 2010-11-16 Boehringer Ingelheim Vetmedica, Inc. Methods of overexpression and recovery of porcine circovirus type 2 ORF2
ES2532861T3 (en) * 2004-12-30 2015-04-01 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions for PCV2 for use in a method of preventing a PCV2 infection
UA95602C2 (en) 2004-12-30 2011-08-25 Берингер Ингельхейм Ветмедика, Инк. Pcv2 immunogenic compositions and methods of producing such compositions
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
CA2604691C (en) * 2005-04-13 2013-12-31 Merial Limited Method for porcine circovirus production and assays for monitoring production
TW200643171A (en) * 2005-06-07 2006-12-16 Temasek Life Sciences Lab Ltd Porcine circovirus type 2 vaccines
PT3127551T (en) 2005-12-29 2020-10-09 Boehringer Ingelheim Animal Health Usa Inc IMMUNOGENIC COMPOSITION OF PCV2 TO ATTENUE CLINICAL SYMPTOMS IN PORK
PL1968630T3 (en) 2005-12-29 2018-08-31 Boehringer Ingelheim Vetmedica, Inc. Multivalent pcv2 immunogenic compositions
EP2859900A1 (en) 2006-12-11 2015-04-15 Boehringer Ingelheim Vetmedica, Inc. Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
CN101558169B (en) 2006-12-15 2017-08-04 贝林格尔.英格海姆维特梅迪卡有限公司 Treatment of pigs with PCV2 antigen
EP1941903A1 (en) 2007-01-03 2008-07-09 Boehringer Ingelheim Vetmedica Gmbh Prophylaxis and treatment of PRDC
EP1958644A1 (en) 2007-02-13 2008-08-20 Boehringer Ingelheim Vetmedica Gmbh Prevention and treatment of sub-clinical pcvd
US7829274B2 (en) 2007-09-04 2010-11-09 Boehringer Ingelheim Vetmedica, Inc. Reduction of concomitant infections in pigs by the use of PCV2 antigen
EP2242511A4 (en) 2008-01-23 2012-10-24 Boehringer Ingelheim Vetmed IMMUNOGENIC PCV2 COMPOSITIONS AGAINST MYCOPLASMA HYOPNEUMONIAE AND METHOD FOR PRODUCING SUCH COMPOSITIONS
WO2009093251A2 (en) * 2008-01-24 2009-07-30 Gavish-Galilee Bio Applications Ltd Reovirus vaccine based on sigma c protein sequence
TWI627281B (en) 2009-09-02 2018-06-21 百靈佳殷格翰家畜藥品公司 Methods of reducing viricidal activity in pcv-2 compositions and pcv-2 compositions with an improved immunogenicity
HUP1100470A2 (en) * 2011-08-30 2013-03-28 Mezoegazdasagi Biotechnologiai Kutatokoezpont Nanoparticle-based veterinary vaccine
EP4091629A1 (en) 2013-09-25 2022-11-23 Zoetis Services LLC Pcv2b divergent vaccine composition and methods of use
KR102409183B1 (en) 2013-10-02 2022-06-15 베링거 인겔하임 애니멀 헬스 유에스에이 인크. Pcv2 orf2 protein variant and virus like particles composed thereof
CN104109704B (en) * 2014-07-09 2016-05-04 福州大学 A kind of isolation and purification method of Recombinant Swine PCV-II capsid protein inclusion body
JP7046607B2 (en) 2015-08-31 2022-04-04 ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー Pestivirus vaccine against congenital tremor
CN111087452A (en) * 2019-12-18 2020-05-01 中国农业科学院兰州兽医研究所 A kind of prokaryotic soluble expression method of porcine circovirus 2b subtype Cap protein
CN111154915A (en) * 2020-01-06 2020-05-15 咸阳职业技术学院 PCR differential diagnosis kit for porcine circovirus type 4 and type 3 and detection method thereof
CN112014561B (en) * 2020-09-03 2022-04-19 扬州大学 Application of porcine circovirus type 4 specific antigen in preparation of kit for detecting porcine circovirus type 4 antibody and kit
CN120535658B (en) * 2022-08-18 2025-12-05 山东信达基因科技有限公司 PCV4-C157 recombinant antigen synthesized based on PCV4-specific protein sequence and its application in the preparation of anti-porcine PCV4-specific antibodies.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA78180C2 (en) * 1997-10-03 2007-03-15 Меріаль Porcine circovirus, vaccines and diagnostic reagents
KR100879650B1 (en) * 1997-12-11 2009-01-20 유니버시티 오브 사스카췌완 Post-weaning polyfunctional wasting syndrome virus from pigs

Also Published As

Publication number Publication date
CA2410229A1 (en) 2001-12-20
WO2001096377A3 (en) 2002-06-13
EP1290016A2 (en) 2003-03-12
JP2004503234A (en) 2004-02-05
MXPA02012352A (en) 2004-09-06
WO2001096377A2 (en) 2001-12-20

Similar Documents

Publication Publication Date Title
AU2001266940A1 (en) Vaccine for congenital tremors in pigs
AU7886301A (en) Transesterification process
GB0020953D0 (en) Vaccine
HUP0301043A3 (en) Vaccine
IL155282A0 (en) Vaccines
AU2001271592A1 (en) Containment system
AU1591402A (en) Vaccine
AU2001258279A1 (en) Adjuvant for vaccines
AU2001253568A1 (en) Lipopolysaccharide-conjugate vaccine for sepsis treatment
GB0014288D0 (en) Vaccine
AU2002214487A1 (en) Method for inducing apoptiosis
AU2001231803A1 (en) Method in trade
AU2001234616A1 (en) Vaccine composition, process and methods
AU2001280674A1 (en) Mini-adenoviral vector system for vaccination
IL141376A0 (en) Large group interactions
AU2002221760A1 (en) Vaccine for treating allergy
AU2001267541A1 (en) Vaccine composition
AU2001259227A1 (en) Method for authenticating artwork
AUPQ726700A0 (en) Containment system
GB0014845D0 (en) Vaccine
AU2001267769A1 (en) Process
GB0003082D0 (en) Vaccine
AU2767201A (en) M cell directed vaccines
GB0004533D0 (en) Vaccines
GB0006693D0 (en) Vaccine